Hisamitsu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hisamitsu Pharmaceutical has a total shareholder equity of ¥267.1B and total debt of ¥1.1B, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are ¥328.8B and ¥61.7B respectively. Hisamitsu Pharmaceutical's EBIT is ¥13.2B making its interest coverage ratio -3.6. It has cash and short-term investments of ¥125.3B.
Key information
0.4%
Debt to equity ratio
JP¥1.15b
Debt
Interest coverage ratio | -3.6x |
Cash | JP¥125.32b |
Equity | JP¥267.08b |
Total liabilities | JP¥61.70b |
Total assets | JP¥328.78b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HTSU.F's short term assets (¥194.0B) exceed its short term liabilities (¥45.9B).
Long Term Liabilities: HTSU.F's short term assets (¥194.0B) exceed its long term liabilities (¥15.8B).
Debt to Equity History and Analysis
Debt Level: HTSU.F has more cash than its total debt.
Reducing Debt: HTSU.F's debt to equity ratio has reduced from 0.7% to 0.4% over the past 5 years.
Debt Coverage: HTSU.F's debt is well covered by operating cash flow (1585.7%).
Interest Coverage: HTSU.F earns more interest than it pays, so coverage of interest payments is not a concern.